High Blood Pressure & Cardiovascular Prevention

, Volume 25, Issue 4, pp 415–416 | Cite as

Measuring Central or Peripheral Blood Pressure Levels? That is the Question in the Modern Clinical Practice of Hypertension

  • Vivianne PrestaEmail author
  • Giuliano Tocci

Over the last decades, blood pressure (BP) levels have been measured at brachial level by conventional sphygmomanometers and, more recently, by validated and accurate automated devices. This method has been systematically applied in observational studies and in large randomized controlled clinical trials for both diagnostic and therapeutic purposes in the clinical management of essential hypertension. As an example, data from the Framingham cohort of individuals have demonstrated the strong and independent relationship between BP levels, mostly systolic, and increased risk of major cardiovascular outcomes, including myocardial infarction, stroke, renal disease, congestive heart failure and cardiovascular death [1]. Similar findings have been observed in various epidemiological surveys in almost all countries all over the world, including Italy [2]. On the other hand, pharmacological and non pharmacological interventions aimed at reducing high peripheral (brachial) BP levels have...


Compliance with Ethical Standards



Conflict of interest

Authors have no conflict of interest to disclose.

Ethical approval

This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.


  1. 1.
    Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138(1):10–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–83.CrossRefPubMedGoogle Scholar
  3. 3.
    Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.CrossRefGoogle Scholar
  5. 5.
    Ghiadoni L, Bruno RM, Stea F, Virdis A, Taddei S. Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension. Curr Hypertens Rep. 2009;11(3):190–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213–25.CrossRefPubMedGoogle Scholar
  7. 7.
    Farag SM, Rabea HM, Mahmoud HB. Effect of amlodipine/valsartan versus nebivolol/valsartan fixed dose combinations on peripheral and central blood pressure. High Blood Press Cardiovasc Prev. 2018. Scholar

Copyright information

© Italian Society of Hypertension 2018

Authors and Affiliations

  1. 1.Hypertension Unit, Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sant’Andrea HospitalUniversity of Rome SapienzaRomeItaly
  2. 2.IRCCS NeuromedPozzilliItaly

Personalised recommendations